Sign in Subscribe
Cancer research

Revolutionizing Cancer Vaccine: The Power of Advanced Nanotechnology

Strategic Insights

— 1 min read

Researchers at Chettinad Hospital and Research Institute have made significant progress in developing effective cancer vaccines using advanced nanotechnology. The study, published in the journal Chemistry, highlights the potential of nanovaccines in inhibiting cancer growth and preventing relapse and metastasis. The researchers emphasize the need for a safer and more effective vaccine, which is the main focus in the field of cancer immunotherapy.

Key Takeaways:

  • The study focuses on various forms of nanovaccines, including lipid-based nanovaccines, metal-based nanovaccines, carbon nanotube-based nanovaccines, PLGA-based nanovaccines, exosome-based nanovaccines, dendritic cell-based nanovaccines, and self-adjuvant nanovaccines.
  • The researchers discussed the therapeutic effects of these nanovaccines in cancer immunotherapy, including their ability to deliver tumor adjuvant or antigen to antigen-presenting cells (APCs) to prevent cancer relapse and metastasis.
  • The study aims to provide a valuable reference for future research and development of nanovaccines for cancer treatment.
  • The research was conducted by Saranya Udayakumar and her team at the Chettinad Hospital and Research Institute in Chennai, India.
  • The study has significant implications for the development of more effective and safer cancer vaccines.

Statistics:

  • The study highlights the potential of nanovaccines in inhibiting cancer growth, with a reported efficacy of excellent in inhibiting cancer growth.
  • The researchers expect that the investigated content will provide a valuable reference for future research and development of nanovaccines for cancer treatment.
  • The study was published in the journal Chemistry, with a DOI of 10.3390/chemistry7030097.
  • The publisher of the journal is MDPI AG, a leading scientific publisher.

Sources:

  • "Revolutionizing Cancer Vaccine: The Power of Advanced Nanotechnology" by Saranya Udayakumar et al., Chemistry, 2025,7(3):97.
  • Journal website: https://doi-org.sdpl.idm.oclc.org/10.3390/chemistry7030097.
  • Contact information for Saranya Udayakumar: Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam, Chennai 603103, India.
  • News article: NewsRx. Research on Cancer Vaccines Published by Researchers at Chettinad Hospital and Research Institute (Revolutionizing Cancer Vaccine: The Power of Advanced Nanotechnology). Vaccine Weekly. July 9, 2025; p 56.

Read more